Cited In for PMID: 17876606

Year	Number of Results
2007	2
2008	2
2009	1
2010	2
2011	3
2012	2
2013	2
2014	5
2015	1
2016	1
2017	1
2018	1
2019	2
2020	2
2021	2
2022	4
2023	1
2024	1

1

Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.

Zheng HC, Tsuneyama K, Takahashi H, Miwa S, Sugiyama T, Popivanova BK, Fujii C, Nomoto K, Mukaida N, Takano Y. Zheng HC, et al. J Cancer Res Clin Oncol. 2008 Apr;134(4):481-8. doi: 10.1007/s00432-007-0310-1. Epub 2007 Sep 18. J Cancer Res Clin Oncol. 2008. PMID: 17876606

2

PIM3 Kinase: A Promising Novel Target in Solid Cancers.

Atalay P, Ozpolat B. Atalay P, et al. Cancers (Basel). 2024 Jan 26;16(3):535. doi: 10.3390/cancers16030535. Cancers (Basel). 2024. PMID: 38339286 Free PMC article. Review.

3

Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma.

Wang C, Chen Q, Luo H, Chen R. Wang C, et al. World J Surg Oncol. 2023 Mar 4;21(1):76. doi: 10.1186/s12957-023-02947-5. World J Surg Oncol. 2023. PMID: 36871027 Free PMC article.

4

Editorial: Premalignant conditions in the esophagus and stomach.

Tustumi F, de Moura DTH, Waisberg J, Herbella FAM. Tustumi F, et al. Front Oncol. 2022 Nov 28;12:1091911. doi: 10.3389/fonc.2022.1091911. eCollection 2022. Front Oncol. 2022. PMID: 36518325 Free PMC article. No abstract available.

5

PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.

Marayati R, Julson J, Bownes LV, Quinn CH, Stafman LL, Beierle AM, Markert HR, Hutchins SC, Stewart JE, Crossman DK, Hjelmeland AB, Mroczek-Musulman E, Beierle EA. Marayati R, et al. Clin Exp Metastasis. 2022 Dec;39(6):899-912. doi: 10.1007/s10585-022-10186-3. Epub 2022 Oct 31. Clin Exp Metastasis. 2022. PMID: 36315303 Free PMC article.

6

The Role of PIM Kinases in Pediatric Solid Tumors.

Julson JR, Marayati R, Beierle EA, Stafman LL. Julson JR, et al. Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565. Cancers (Basel). 2022. PMID: 35892829 Free PMC article. Review.

7

Multi-stage analysis of FOXM1, PYROXD1, hTERT, PPARA, PIM3, BMI1 and MCTP1 expression patterns in colorectal cancer.

Shabani S, Elahi E, Bahraniasl M, Babaheidarian P, Sadeghpour A, Majidzadeh T, Talebi A, Mahjoubi F. Shabani S, et al. Gastroenterol Hepatol Bed Bench. 2022 Spring;15(2):120-130. Gastroenterol Hepatol Bed Bench. 2022. PMID: 35845311 Free PMC article.

8

Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer.

Tandon N, Luxami V, Kant D, Tandon R, Paul K. Tandon N, et al. RSC Adv. 2021 Jul 20;11(41):25228-25257. doi: 10.1039/d1ra03979b. eCollection 2021 Jul 19. RSC Adv. 2021. PMID: 35478899 Free PMC article. Review.

9

Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products.

Park H, Jeon J, Kim K, Choi S, Hong S. Park H, et al. Pharmaceuticals (Basel). 2021 Mar 18;14(3):275. doi: 10.3390/ph14030275. Pharmaceuticals (Basel). 2021. PMID: 33803840 Free PMC article.

10

High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.

Motylewska E, Braun M, Stępień H. Motylewska E, et al. Endocr Pathol. 2020 Sep;31(3):264-273. doi: 10.1007/s12022-020-09629-y. Endocr Pathol. 2020. PMID: 32504181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year